Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells
Tülin Özkan, Yalda Hekmatshoar, Arzu Zeynep Karabay, Aslı Koç, Buket Altınok Güneş, Aynur Karadağ Gürel, Asuman Sunguroğlu
Topics & Concepts
K562 cellsViability assayApoptosisImatinibMyeloid leukemiaChronic myelogenous leukemiaCancer researchP-glycoproteinFlow cytometryPharmacologyLeukemiaChemistryMultiple drug resistanceBiologyMolecular biologyDrug resistanceImmunologyMicrobiologyBiochemistryChronic Myeloid Leukemia TreatmentsDiverse Scientific Research StudiesSynthesis and biological activity